Welcome to LookChem.com Sign In|Join Free
  • or
(E)-2-(3,4-dimethoxyphenyl)-3-fluoroprop-2-en-1-ol is a complex organic compound characterized by a fluorinated propenol structure. It features a 3,4-dimethoxyphenyl group attached to the 2-position of the propenol backbone, which is in the E-configuration, indicating the geometric arrangement of the double bond. The molecule consists of a hydroxyl group at the 1-position, a fluorine atom at the 3-position, and two methoxy groups at the 3 and 4 positions of the phenyl ring. (E)-2-(3,4-dimethoxyphenyl)-3-fluoroprop-2-en-1-ol is known for its potential applications in the synthesis of pharmaceuticals and agrochemicals, particularly as a building block for the creation of more complex molecules. Its unique structure and functional groups make it an interesting target for chemical research and development.

85277-86-7

Post Buying Request

85277-86-7 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

85277-86-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 85277-86-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,5,2,7 and 7 respectively; the second part has 2 digits, 8 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 85277-86:
(7*8)+(6*5)+(5*2)+(4*7)+(3*7)+(2*8)+(1*6)=167
167 % 10 = 7
So 85277-86-7 is a valid CAS Registry Number.

85277-86-7Relevant academic research and scientific papers

NEW ARYLALKENYLPROPARGYLAMINE DERIVATIVES EXHIBITING NEUROPROTECTIVE ACTION FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES

-

Page/Page column 98, (2015/06/25)

The invention relates to novel arylalkenylpropargylamine derivatives of general formula (I) or enantiomers or diastereomers thereof or salts, optionally pharmaceutically acceptable salts, or solvates of any of these. The compounds can be used in treating or preventing a disease or condition in a mammal related to monoamine oxidase dysfunction, especially in neurodegenerative diseases, e.g. Parkinson's disease, Alzheimer's disease or Huntington's disease.

Enzyme-activated irreversible inhibitors of monoamine oxidase: Phenylallylamine structure-activity relationships

McDonald,Lacoste,Bey,Palfreyman,Zreika

, p. 186 - 193 (2007/10/02)

Seventeen 2-aryl-3-haloallylamine derivatives were prepared and evaluated as inhibitors of monoamine oxidase (MAO, EC 1.4.3.4). The synthesis of these compounds was achieved from either α-methylstyrene or ring-substituted phenylacetic acid derivatives. Wi

Allyl amine MAO inhibitors

-

, (2008/06/13)

Compounds of the formula STR1 wherein: R is phenyl, phenyl monosubstituted, disubstituted, or trisubstituted by (C1 -C8) alkyl, (C1 -C8)alkoxy, hydroxy, chlorine, bromine, iodine, fluorine, trifluoromethyl, nitr

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 85277-86-7